| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| unguentum cocois-salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| lanolin 4 % + zinkoxid 8 % |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| tvålersättning + zinkoxid 5 %, krämtvål |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Urea 100 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely lauromacrogol 30 milligram/1 gram and urea 50 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely urea 100 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Lactic acid 50 mg/g and urea 100 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| cetyldimetikon 5 %, badolja |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| sojaolja + blandade lauromakrogoler 82,95/15 %, badolja |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| sojaolja 84,75 %, badolja |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Talc dusting powder BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Zinc+starch+talc dusting powder BPC |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Calamine compound application BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Calamine 4% aqueous cream BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Calamine lotion BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| fet lotion innehållande kalamin |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Calamine 15% ointment BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely crotamiton 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Crotamiton 100 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine 25 milligram/1 gram and prilocaine 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Benzocaine 30 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Benzocaine 10 mg/mL and triclosan 2 mg/mL cutaneous spray |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Benzocaine 10 mg/g and triclosan 2 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely diphenhydramine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Doxepin hydrochloride 50 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| hydrokortisonkrämer |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| hydrokortisonsalvor |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone 25 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Hydrocortisone acetate 10 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Crotamiton 100 mg/g and hydrocortisone 2.5 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely clioquinol 30 milligram/1 gram and hydrocortisone 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Clioquinol 30 mg/g and hydrocortisone 10 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone acetate 10 milligram/1 gram and sodium fusidate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Fusidic acid 20 mg/g and hydrocortisone acetate 10 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Econazole nitrate 10 mg/g and hydrocortisone 10 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Hydrocortisone 10 mg/g and miconazole nitrate 20 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone 10 milligram/1 gram and miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| hydrokortison 10 milligram/gram och klotrimazol 10 milligram/gram, hudkräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Alclometasone dipropionate 500 microgram/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely alclometasone dipropionate 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely beclometasone dipropionate 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| betametasonvalerat 0,12 %, skum |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone valerate) 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| betametason 0,1 %, för applicering i hårbottnen |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| betametason 0,1 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| betametason 0,1 %, salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| betametason 0,1 %, lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| betametason 0,05 % + salicylsyra 3 %, för applicering i hårbottnen |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| betametason (som betametasondipropionat) 500 nanogram/milligram, kutan salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone valerate) 1 mg/g and fusidic acid 20 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone valerate) 1 mg/g and neomycin sulfate 5 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone valerate) 1 mg/g and clioquinol 30 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and clioquinol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Clobetasone butyrate 500 microgram/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Clobetasone butyrate 500 microgram/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| deoximetason 0,05 %, fet kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| diflukortolonvalerat 0,1 %, fet kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely diflucortolone valerate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| diflukortolonvalerat 0,3 %, fet kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Diflucortolone valerate 3 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Fluocinolone acetonide 250 microgram/g cutaneous gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely fluocinolone acetonide 250 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely fluocinolone acetonide 62.5 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely fluocinolone acetonide 25 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Fluocinolone acetonide 250 microgram/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely fluocinonide 500 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| fluokortolon 0,5 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| fluokortolon 0,5 %, salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely fludroxycortide 125 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely halcinonide 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous emulsion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Clorquinaldol 30 mg/g and hydrocortisone butyrate 1 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Hydrocortisone butyrate 1 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| hydrokortisonbutyrat 0,1 %, fet kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| hydrokortisonbutyrat 0,1 %, emulsion för hårbottnen |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| triamcinolon 0,1 % + klortetracyklinhydroklorid 3 %, salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone acetate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Mometasone furoate 1 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|